Data and technology · Practitioner guidance

Low-Code and No-Code Application Validation

Separate managed-platform controls from locally configured GxP workflows, rules, permissions, interfaces, data, records, and releases.

Author
Sandip Thorat
Published
12 September 2026
Last reviewed
12 September 2026
Version
1.0
Content type
Practitioner guidance
Primary references
2 linked sources in this guide

Define the validation boundary

Assess the platform and supplier, approved intended use, GxP impact, local configuration, business rules, workflow, permissions, interfaces, data, electronic records and signatures, development or configuration environment, release management, testing, change control, and citizen-developer governance where applicable.

Platform qualification can support standard services such as identity, audit logging, deployment, backup, and availability. It does not prove that a locally built approval rule, calculation, integration, role matrix, or record lifecycle performs as intended.

Completed fictional CAPA intake application

A Quality team configures a low-code application to intake CAPA requests, route triage, assign owners, require due dates, and create a draft record in the controlled eQMS. The app cannot approve or close CAPA records. Risks include omitted mandatory information, incorrect priority, unauthorized reassignment, duplicate eQMS creation, and missing source-to-target traceability.

Testing scripts mandatory fields, role permissions, routing and due-date rules, duplicate prevention, eQMS acknowledgement, audit entries, and record linkage. Exploratory testing challenges interrupted saves, concurrent editing, resubmission, mobile behavior, and exceptional ownership changes. Supplier evidence is used for the unchanged platform deployment service; local configuration and integration are tested by the customer.

The first execution finds that a service account can bypass the screen rule and submit an incomplete record. A server-side rule and permission correction are implemented and retested before release.

Regulatory and procedural context

Primary sources. FDA CSA guidance is relevant to risk-based assurance for applicable production and quality-system software. EU GMP Annex 11 is relevant to configured systems used in applicable GMP activities.

Company procedure. The organization’s approved validation, change-control, supplier-management, information-security, data-integrity, records-retention, and Quality approval procedures determine the required records, roles, and approval route.

CSVtoCSA practitioner interpretation. Treat low-code configuration as software functionality when the regulated process relies on it; avoid assuming the platform’s validation covers local behavior. This is a recommended validation approach, not a statement that every listed activity is a direct regulatory requirement.